Dr Jeffrey Penner, PHD | |
8885 Rio San Diego Dr, Suite 325, San Diego, CA 92108-1624 | |
(619) 297-8640 | |
(619) 297-0122 |
Full Name | Dr Jeffrey Penner |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 44 Years |
Location | 8885 Rio San Diego Dr, San Diego, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104178078 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 7094 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Penner, PHD 8885 Rio San Diego Dr, Suite 325, San Diego, CA 92108-1624 Ph: (619) 297-8640 | Dr Jeffrey Penner, PHD 8885 Rio San Diego Dr, Suite 325, San Diego, CA 92108-1624 Ph: (619) 297-8640 |
News Archive
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).
Frost & Sullivan has announced 44 world-class companies as winners of the 2015 CIO Impact Awards. The recipients are comprised of enterprise teams, individuals, and technology partners enabling breakthrough new business models and strategies through the innovative use of transformative technologies.
Dr. Joan Fallon, founder and CEO of Curemark, a Rye, New York-based drug research and development company focused on the treatment of Autism and neurological diseases, today announced that the company has received clearance from the Food and Drug Administration (FDA) to commence direct enrollment of children 9-12 years of age into its open-label extension study of CM-AT for children with Autism.
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
› Verified 8 days ago
Dr. Douglas Brackmann, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3101 4th Ave, San Diego, CA 92103 Phone: 858-735-1667 Fax: 619-542-0332 | |
Barton Palmer, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Vasdhs Division Of Geriatric Psychiatry 116a, 3350 La Jolla Village Drive, San Diego, CA 92161 Phone: 858-552-8585 | |
Dr. Lina Kogan-sbarbaro, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1050 University Ave Ste E107, San Diego, CA 92103 Phone: 858-504-7743 Fax: 858-216-1928 | |
Dr. Raymond Peng, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 6540 Lusk Blvd Ste C159, San Diego, CA 92121 Phone: 858-888-9683 | |
Meghan Hammel, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 West Arbor Drive, San Diego, CA 92103 Phone: 619-543-2827 | |
Dr. Rodger Stacy Questin, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 3702 4th Ave, San Diego, CA 92103 Phone: 760-607-7257 | |
Dr. Jessica Lynette Montoya, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 |